Dr. Orland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195
Education & Training
University of Illinois College of MedicineClass of 2022
Certifications & Licensure
OH State Medical License 2023 - 2025
Publications & Presentations
PubMed
- 2 citationsOutcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapy.Danai Dima, Michael Hughes, Mark Orland, Fauzia Ullah, Utkarsh Goel
Amyloid. 2024-09-01 - Clinical Efficacy of Retreatment With Venetoclax-Based Therapy in Relapsed-Refractory t(11;14) Multiple Myeloma.Danai Dima, Mark Orland, Fauzia Ullah, Faiz Anwer, Sandra Mazzoni
Clinical Lymphoma, Myeloma & Leukemia. 2023-11-01 - Immunotherapy for Head and Neck Squamous Cell Carcinoma: Present and Future Approaches and Challenges.Mark D Orland, Fauzia Ullah, Emrullah Yilmaz, Jessica L Geiger
JCO Oncology Practice. 2024-05-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
